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Computational Approaches for Prioritizing Candidate Disease Genes
Based on PPI Networks
Wei Lan, Jianxin Wang , Min Li , Wei Peng, and Fangxiang Wu
Abstract: With the continuing development and improvement of genome-wide techniques, a great number of
candidate genes are discovered. How to identify the most likely disease genes among a large number of candidates
becomes a fundamental challenge in human health. A common view is that genes related to a specific or similar
disease tend to reside in the same neighbourhood of biomolecular networks. Recently, based on such observations,
many methods have been developed to tackle this challenge. In this review, we firstly introduce the concept of
disease genes, their properties, and available data for identifying them. Then we review the recent computational
approaches for prioritizing candidate disease genes based on Protein-Protein Interaction (PPI) networks and
investigate their advantages and disadvantages. Furthermore, some pieces of existing software and network
resources are summarized. Finally, we discuss key issues in prioritizing candidate disease genes and point out
some future research directions.
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1

Introduction

Hereditary diseases are usually caused by some
mutations of single or multiple genes in human
genome. According to the number of mutated genes
which are related to diseases, genetic disorders can be
classified to single gene disorders (Mendelian disorder)
and polygenic disorders (complex disorder)[1] . More
than 4000 human diseases, such as duchenne muscular
dystrophy, polycystic kidney disease, and sickle cell
anemia, are caused by single gene mutation. However,
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most of these diseases are uncommon, for example,
the incidence of Huntington’s disease is approximate
1/15 000[2, 3] . In contrast, polygenic disorders such as
cancers which are influenced by multiple genes and
environmental factors are more common in public
health. Discovering genes causing these diseases
would assist biomedical researchers to understand the
underlying mechanisms of actions, further conduce to
disease diagnosis and treatment.
With the development of high-throughput techniques,
a great deal of biological data has been and will
continue to be generated. At present, there are two
main genetic mapping approaches to generate candidate
disease genes. The first is linkage analysis that aims
at finding out the rough location of the gene relative
to another DNA sequence called a genetic marker,
which has its position already known. The second is
Genomic-Wide Association Studies (GWAS) which are
successful in detecting associations between variants
and genetic disorders[4] . Both of these two types of
approaches can find thousands of candidate disease
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genes, but how to identify the most likely disease genes
from these candidates is a great challenge for molecular
biologists and medical geneticists. As limitations of
experimental approaches such as time and labour, it is
appealing to develop efficient computational methods to
tackle this obstacle.
Recently, some computational approaches have been
proposed to prioritize candidate disease genes from
Protein-Protein Interaction (PPI) network[5–7] . The PPI
network is one of the most important biological
networks which has been widely used to predict protein
functions[8–10] , detect protein complexes[11, 12] , identify
essential proteins or genes[13, 14] , and discover network
motifs[15] . A PPI network can be presented as an
undirected graph G.V; E/ where a set of nodes (V )
denote proteins together while a set of edges (E)
denote interactions between proteins. The emergence
of disease is usually viewed as a consequence of
perturbation of a PPI network[16, 17] , as shown in
Fig. 1. Mutation of nodes, removal of edges or anomaly
in modules all can cause different diseases. In this
review, our aim is to summarize these approaches
which are used to prioritize candidate disease genes
based on PPI networks and try to assist readers to
keep up with recent and important developments in this
filed. The paper is organized as follows: In the second
section, we introduce some available data resources
for candidate gene prioritization. In the third section,
we present the recent computational approaches. In the
fourth section, existing and available tools based on PPI
data are summarized. Then the paper concludes with

Fig. 1 The association between disease and PPI networks
due to the perturbation of PPI networks. Abnormal of nodes,
edges, and modules may all lead to disease. (a) The normal
PPI network; (b) The node variation in the PPI network; (c)
The interaction removal in the PPI network; and (d) The
module abnormality of the PPI network.
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highlighting the key issues and the future discussions
of this filed.

2

Biological Data Resources

Recently, with the rapid increase of biological data,
some specific databases have been built to store
and manage these data. These available resources
have greatly improved disease gene prioritization by
providing various biological data to researchers for
constructing computational models. In the rest of this
section, we describe the public biological data in terms
of different categories.
2.1

Disease gene data

Genomic-wide association studies provide an effective
way to explore the genetic basis of complex traits. The
disease data have been dramatically increased with
the development of genotyping technology. Many
disease repositories have been built to collect and store
these data. Here, we describe three important disease
databases, as shown in Table 1. Online Mendelian
Inheritance in Man (OMIM)[18] is a comprehensive
database of human genes and genetic disorders,
which is maintained by McKusick-Nathans Institute of
Genetic Medicine, School of Medicine, Johns Hopkins
University. Up to July 2015, there are 23 034 entries:
14 972 for gene description, 86 for the combination
of genes and phenotypes, 4499 for molecular basis
known phenotype description, 1654 for molecular basis
unknown phenotype description or locus, and 1823
for phenotypes with suspected Mendelian basis. The
phenotypes of OMIM database primarily describe
single gene Mendelian disorders, and also the complex
traits for which mutation in a single gene result
in a significant contribution to the phenotype. The
Genetic Association Database (GAD)[19, 20] is a webbased knowledgebase of human complex diseases
and disorders. The summary data are extracted from
published papers. There are 5526 diseases classified
into 19 categories such as cancer, aging, immune,
and so on. The GAD contains 167 130 records, out
of which 82 285 records are given a description of
whether they are reported to be associated or not
with the disease phenotype for that specific record or
not. The DisGeNET database[21] integrates associations
from several sources that cover different biomedical
aspects of diseases and thus provides comprehensive
gene-disease association information. The DisGeNET
contains 100 729 associations between 9313 genes
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Table 1

An overview of disease gene database.

Database

Disease

Genes

Records

URL

Reference

OMIM
GAD
DisGeNET

Over 7000
5526
6029

14 972
about 8000
9313

23 034
167 130
100 729

http://www.omim.org/
http://geneticassociationdb.nih.gov
http://ibi.imim.es/DisGeNET/web/v02/home

[18]
[19, 20]
[21]

and 6029 diseases including Mendelian, complex, and
environmental diseases.
2.2

PPI data

With the development of high-throughput technologies
such as yeast two-hybrid map, immunoprecipitation,
and mass spectrometry technology, a mass of PPI
information has been obtained[22–24] . The alternative
way to gain PPI data is based on co-occurrence
in Ref. [25] and some databases have been built
to store literature-based PPI information such as
the Biomolecular Interaction Network Database
(BIND)[26] , the Database of Interacting Proteins
(DIP)[27] , the Molecular INTeraction (MINT)
database[28] , and the protein InterAction (IntAct)
database[29] . Table 2 presents an overview of PPI
database.
More recent PPI curation efforts have attempted
larger scale curation of data, such as the
Biological General Repository for Interaction
Datasets (BioGRID)[30] and the Human Protein
Reference Database (HPRD)[31] . The BioGRID
(http://thebiogrid.org/)[30] is a database of physical
and genetic interactions, which contains 36 species
and 471 829 interactions in the recent version. The
Homo sapiens has 17 624 proteins and 130 503
interactions. The HPRD (http://hprd.org/)[31] is a
repository of human protein information, which
provides PPI data, Post-Translational Modifications
(PTMs), and tissue expression data. The latest
version of HPRD contains 30 047 proteins and
Table 2

41 327 interactions. In addition, Search Tool for
the Retrieval of Interacting Genes (STRING)[32] and
Human Integrated Protein-Protein Interaction rEference
(HIPPIE) databases[33] try to construct comprehensive
PPI dataset by integrating different organisms or data
resources. The STRING database (http://string-db.org)
contains protein interaction information in approximate
1100 organisms where protein-protein associations
are weighted in term of scoring scheme. The textmining information has been updated into new
version[32] . The HIPPIE database (http://cbdm.mdcberlin.de/tools/hippie) provides comprehensive PPI
dataset by integrating multiple experimental PPI
resources with normalized scoring scheme[33] .

3

Prioritizing Disease Genes Based on PPI
Networks

In the following, we review computational approaches
of disease gene prioritization from PPI networks. The
core concept of disease gene prioritization from a PPI
network is that genes associated with phenotypically
close disorders are likely to locate closely to each other
in the PPI network[34–36] .
3.1

Distance-based methods

The assumption of disease gene prioritization
is mostly based on the principle of “guilt-byassociation”[34] . Hence, the distance between candidate
disease genes and known disease genes seems a good
way for disease gene prioritization. If a candidate
disease gene has a long distance to the known disease

An overview of protein-protein interaction database.

Database

Species

Number of entries

URL

BIND
DIP
MINT
IntAct
BioGRID
HPRD
STRING
HIPPIE

About 1500 species
10 species
6 species
Over 15 species
51 species
Homo Sapiens
Over 1100 species
Homo Sapiens

200 000 interactions
25 612 proteins and 75 400 interactions
35 511 proteins and 241 458 interactions
65 200 proteins and 312 217 interactions
471 829 interactions
30 047 proteins and 41 327 interactions
5 million proteins and 200 million interactions
72 916 interactions

http://bind.ca
http://dip.doe-mbi.ucla.edu
http://mint.bio.uniroma2.it/mint
http://www.ebi.ac.uk/intact
http://thebiogrid.org
http://hprd.org
http://string-db.org
http://cbdm.mdc-berlin.de/tools/hippie

Reference
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[33]
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genes, then it has a low chance to be a disease gene. The
simplest method to measure the distance between two
given genes is to detect whether their corresponding
proteins are connected directly in the PPI network. Oti
et al.[37] proposed a direct neighbour-based method
to predict disease candidates with known disease
loci. Hsu et al.[38] introduced a nearest-neighbour-based
method to prioritize disease genes. They used the
interconnectedness (ICN) to evaluate the closeness
between the candidate disease genes and the known
disease genes.
Considering that disease genes are generally involved
in same pathways instead of physically interacting,
the direct neighbour method fails to capture this
kind information. Some researchers use the shortest
path method to measure the closeness between two
proteins. Zhu et al.[39] proposed a Vertex Similarity
(VS) method based on shortest paths to rank orphan
disease genes. In consideration of the fact that gene with
similar function shared with similar disease, Li et al.[40]
proposed two shortest path methods, called SPranker
and SPGOranker, to prioritize disease-causing genes in
protein interaction networks.
Apart from local distance measures such as the
shortest path method, the global network distance is
an alternative method to measure the distance between
candidate disease genes and known distance genes. By
using Random Walk with Restart (RWR) and diffusion
kernel methods, Köhler et al.[41] proposed two methods
to assess the similarity of two genes in the PPI
network for disease gene prioritization. Similar work
has been done by Erten et al.[42] They developed the
VAVIEM method for disease gene identification. The
RWR and Pearson Correlation Coefficient (PCC) are
combined to measure similarity of two proteins. Le
and Kwon[43] further proposed a neighbour-favouring
weight reinforcement to improve the performance of
RWR in disease gene prioritization. They showed
that when only the interactions between the nearest
neighbours and known disease gene are reinforced, the
performance is optimal. More recently, Zhang et al.[44]
proposed a method, named ESFSC, based on RWR to
rank candidate disease genes. The innovation of ESFSC
is enlarging seed nodes with known disease genes and
their k-nearest neighbour nodes.
3.2

Disease-specific
methods

or

tissue-specific

based

It is well known that the PPI data contain various
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noises[45–47] . Using PPI data as a single resource for
disease gene prioritization will lead to the potential
bias of results. An effective method to overcome this
shortage is integrating different data resources, such as
gene expression, Gene Onthology, etc[48] .
The reconstruction of disease-specific PPI networks
is based on the fact that biological networks are
highly modular. Comparing to generic PPI networks,
disease-specific PPI networks can further reveal the
underlying mechanisms and features of diseases and
contribute to identifying potential disease genes in a
more accurate way. Wang et al.[49] reconstructed a
Disease-Aging Network (DAN) by integrating diseasegene association, aging-gene association, and human
PPI data. The topological properties of DAN are
analysed thoroughly and diseases can be classified
into two catalogues: disease genes in catalog I are
significantly close to aging genes, but in catalog II
are not. Lee et al.[50] constructed a PPI network
of abnormally expressed genes of three kinds of
diseases (schizophrenia, bipolar disorder, and major
depression) by incorporating microarray and PPI
data. The abnormally expressed genes are selected by
analysing microarray data with t -test. Some significant
disease genes are identified by analysing topological
features of disease-specific PPI network. Zhao et al.[51]
constructed an axial spondyloarthropathy specific PPI
network by combining OMIM database, proteomics
and microarray experiment data. The topological and
pathway features of the PPI network are analysed and
some new insights of pathogenesis are found. He et
al.[52] built context-specific PPI networks by selecting
genes existing in the PPI networks and expressed
at the same time. The information flow method
is used to identify dysfunctional modules and the
candidate disease genes are prioritized via integrating
semantic similarity and module analysis. Based on
the hypothesis that integrating PPI networks with
mRNA expression profiles may contribute to delineate
dysregulated molecular sub-networks which contain
disease-causing genes, Lee et al.[53] proposed an
approach to identify acute myeloid leukemia disease
genes. This method overlays expression values of each
gene on its corresponding protein in PPI network
and identifies significant sub-networks by calculating
Perturbation Score (PS) of each sub-network.
The study of tissue-specific protein interactions is
still at the initial stage. Proteins whose genes are
translated more efficiently in a specific tissue tend to
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have more connections within this tissue as compared to
other proteins in the same tissue[54, 55] . Magger et al.[56]
pointed out that many present methods use static human
PPI data to prioritize disease gene, but the disease
impact specific tissue corresponding PPI network may
be dramatically different. They construct a tissuespecific PPI network by integrating tissue-specific
gene expression data and employ existing prioritization
methods to compare experimental result between
the tissue-specific PPI network and the generic PPI
network. The results demonstrate that tissue-specific
PPI network can effectively improve the performance
of prioritization. In addition, Li et al.[57] constructed
weighted tissue-specific network by combining gene
expression and DNA methylation data and pagerank based method used to rank candidate disease
genes. Their results demonstrate that the performance of
weighted tissue-specific network is better than original
protein interaction network.
3.3

Multiple-network methods

It has been demonstrated that phenotypically similar
diseases often share a set of functional similar
genes[58] . With this observation, disease similarity
networks can be constructed by using phenotype
similarity data. In addition to phenotype similarity data,
other biological data such as Gene Ontology (GO) and
pathway information also are used to construct specific
network[59] .
3.3.1

Integration of phenotypic information

Based on assumption that a group of functionally
related genes may be bound up with phenotypically
similar diseases[58] , some studies have been conducted
by combining phenotypically similar profiles and PPI
data for disease gene prioritization.
Wu et al.[60] proposed the CIPHER method based
on linear regression to predict and prioritize disease
genes. The concordance score upon phenotype
similarity is employed to evaluate the consistency
between the position genes in the PPI network
and the variation of phenotype similarity for the
phenotype network and used to rank all candidate
disease genes. Zhang et al.[61] developed a Bayesian
regression method based on the linear relation
between disease phenotype and gene proximity to
disease gene prioritization. For a query disease and
a candidate gene, Bayes factors, which indicate the
strength of association between disease similarity
and gene proximity, are computed to rank candidate

genes. The results showed that Bayess approaches
can more effectively enhance performance than
CIPHER in identifying disease genes. In addition, Yao
et al.[62] developed a HItting-Time-based approach
(CIPHER-HIT, as a continuation of CIRHER) to
prioritize candidate disease genes. Unlike CIPHER, the
CIPHER-HIT captures the global relationships instead
of local ones. The Mean-Hitting-Time of the random
walk on the heterogeneous network is used to measure
the closeness of two nodes for disease gene ranking
and the condition of Mean-Hitting-Time is employed
to find modularity characteristics for disease subtype
inference. Yang et al.[63] also proposed a method called
RWPCN (Random Walk on Protein Complex Network)
to predict and prioritize disease genes. Different
types of computational methods have been proposed
for the identification of protein complexes, such as
IPCA[64] which has been used successfully in the
studies of rheumatoid arthritis[65] . Li and his fellows[66]
constructed a multi-graph by merging different data
resources (include PPI and three ontologies) and
phenotype network by using phenotype data. The
extensional random walk with restart, Random Walk
with Restart on Multigraphs (RWRM) is employed to
prioritize disease gene on multi-graph and phenotype
network. The result demonstrates that the performance
of RWRM exceeds the state-of-the-art approaches in
disease gene identification. In addition, Xie et al.[67]
introduced a Bi-Random Walk (BiRW) algorithm to
unveil the associations between the complete collection
of disease phenotypes (phenome) and genes.
Vanunu et al.[68] presented a network propagation
method called PRINCE to identify disease genes and
protein complexes by using disease-disease similarity
and PPI data. The input is a query disease, and then the
resembled disease is selected by computing phenotypic
similarity of two diseases. The score function based
on network propagation is designed to rank disease
genes. In each propagation process, the genes receive
the flow from its neighbours which receive the flow
from the previous iteration. The final score of each gene
is the amount of flows. The performance of PRINCE
surpasses random walk and CIHPER. However, the
PRINCE computes disease-gene association scores
based on the association between the disease similar
to the query disease and their involved genes
independently. Guo et al.[69] proposed a framework
to prioritize candidate disease genes by exploiting
modular nature of the genetic diseases and the
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consistency between the disease phenotypic overlap and
the genetic overlap. The association score between a
query disease and a candidate gene is defined as the
sum of all association scores between the neighbour of
candidate genes and the diseases which are similar to
the query disease. The result shows it outperforms the
PRINCE. More recently, Ganegoda et al.[70] constructed
tissue specific gene network and phenotype-phenotype
network and detected the similarity between seed genes
and candidate genes.
In addition, information flow based methods and
network alignment methods have been developed
to prioritize disease genes in phenotype and PPI
networks. Chen et al.[71] utilized MAXimizing
Information Flow (MAXIF) approach to measure the
strength of association between a query disease and
a candidate gene. Experimental results have showed
that the MAXIF is superior to PRINCE. Wu et al.[72]
proposed network alignment based framework, called
AlignPI, to identify and predict disease genes from
gene network and phenotype network. The network
alignment toolkit can be obtained from Ideker lab
(http://chianti.ucsd.edu/nct/index.php) and is employed
to find pairs of sub-networks called gene module
(gene sub-network) and disease module (disease subnetwork), by aligning gene and phenotype network. The
DAVID tool[73] is used to analyse gene function of
module and Fisher exact test is used to calculate the
P -value of enriched disease category. The results
showed AligPI is better than CIPHER in performance
and phenotypic overlap is a general indicator of shared
pathogenesis.
3.3.2

Integrating other biological information

The GO is a repository of biological knowledge, which
contains three independent sub-ontologies: biological
process, cellular component, and molecular function. Li
and Patra[74] demonstrated that these sub-ontologies are
independent. Therefore, three gene functional similar
networks can be constructed by calculating functional
similarity. The random walk with restart method is
used to rank disease genes in four networks (three subontology networks and one PPI network), and then
the rank lists are transformed into discounted rating
lists through a Discounted Rating System (DRS). The
discounted rating scores of genes in different networks
are combined to rank these disease genes. The results
showed that the discounted rating system method
is comparable with N -Dimensional Order Statistics
(NDOS) used in Endeavour in terms of performance
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and faster than NDOC in terms of the working speed. In
addition, Chen et al.[75] constructed gene co-expression
network, PPI network, and pathway network by using
three specific data resources (PPI, gene co-expression,
and pathway networks) for gene prioritization. The
importance of two genes similarity in different networks
is defined in view of Diffusion Kernel approach
(DK) and further Data Integration Rank (DIR) can
be calculated in term of similarity. The final DIR
score is employed to evaluate the association between
candidate gene and known disease genes of specific
diseases. It defines a meta score method instead of using
the top-K approach to report prioritization result. The
informativeness of networks for specific disease is also
discussed in that paper.
3.4

Machine learning methods

Machine learning is a useful tool to prioritize candidate
disease genes by training classifiers with features of
known disease genes and non-disease genes.
Supervised machine learning prioritizes candidate
genes based on the differences between disease
genes and non-disease genes of biological
knowledge. Hindumathi et al.[76] investigated the
cervix related cancer by means of combining PPI
data and cancer gene data. The topological properties
(such as vulnerability, closeness, centroid values,
shortest-path betweenness centrality, current flow
betweenness centrality, and eigenvector centrality)
and gene ontology enrichment analysis are employed
to classify the cervix related cancer genes and nondisease genes. Besides topological features, Jia et
al.[77] integrated other biological features to predict
disease genes of autism spectrum disorders and
intellectual disabilities. Eleven features (GO biological
processes, GO cellular components, GO molecular
functions, transcription factor binding sites, metabolites
associated with gene-lists, knockout mouse phenotypes,
microRNA targets, structural domains, hub proteins,
and gene signatures) are chosen to train three classifiers
(two network-based and one attribute-based). The
Matthew’s Correlation Coefficient (MCC), accuracy,
sensitivity, specificity, and Area Under the ROC
Curve (AUC) are used to evaluate the classifier’s
performance. Gene expression data can be viewed as
an indicator that a gene is abnormal or not. Nitsch et
al.[78] combined different gene expression datasets with
PPI data and developed a web-based machine learning
method to prioritize disease genes. Four strategies
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(three of them are based on random walk while one
is based on direct neighbourhood) are designed to
train classifiers. Their assumption is that a disease
gene is surrounded by highly differentially expressed
genes in PPI networks. Chen et al.[79, 80] utilized the
biological features of protein complex, expression
profile, pathway to identify disease gene based on
Bayesian analysis and Markov random field method. In
addition, Chen et al.[81] presented a multiple regression
model with lasso penalty method to discover genes
associated with a disease. The sequence, network,
expression, and pathway semantic and phenotypic
features are selected to classify disease genes and
non-disease genes.
Supervised learning methods based on hypothesis
that the separation of disease genes and non-disease
genes has been used to prioritize candidate disease
genes. However, a limited number of discovered genes
are as yet-unidentified genes which should be taken
into account for prediction process. Nguyen and Ho[82]
proposed a semi-supervised learning approach which
takes yet-unidentified genes into consideration to detect
disease genes. Several features including topology,
keyword, enzyme, sequence length, GO term, protein
domain, and biological pathway are chosen to train
classifiers. In addition, Mordelet and Vert[83] developed
ProDiGe, a multi-task machine learning method to
prioritize disease genes. ProDiGe exploits the relative
similarity of both known and candidate disease genes
to jointly score, instead of scoring independently the
different candidate genes. Moreover, this method also
gathers the information from known disease genes and
important role of genes in similar diseases to rank
candidate disease genes. The challenge of machine
learning method is how to select useful biological
Table 3

Training data

MetaRanker
ENDEAVOUR
GeneDistiller
GUILDify
ProphNet
ProDiGe

4

Computational Tools for
Disease Gene Prioritization

Known genes
Expression dataset
Keywords
Known genes, keywords and
expression dataset
Known genes and keywords
Known genes
Known genes
Known genes
Known genes

Candidate

In the past few years, a large number of computational
tools have been developed to assist biologists to
prioritize disease genes[88–90] . In this section, we
describe some current available candidate disease
gene prioritization tools which can be used with
PPI data. Table 3 presents brief comparison of these
computation tools.
4.1

Gene prioritization web-based tools

The inputs of these web tools can be classified
into two categories: candidate disease genes and
prior knowledge of disease-related. Some tools, such
as ToppNet[91] , Gentrepid[93] , Endeavour[95] , and
GUILDify[97] , require users to upload a specific
candidate gene set for disease gene prioritization. Other
tools, including GeneDistiller[96] , MetaRanker[94] and
PINTA[92] , provide whole genomic prioritization sever
without any candidates. The user can choose specific

A brief comparison of computational tools.
Input

Tools
ToppNet
PINTA
Gentrepid

features to train classifier[84] . Therefore, integrating
multiple data resource is an effective method to improve
performance. However, the redundant or irrelevant
biological information may be futile even degrade
the performance. How to select useful features from
various biological resources would be further research
focus. As some topological characters have been used
both for the identification of essential proteins and
disease genes, we can also borrow some features used in
the identification of essential proteins[85–87] . In addition,
the different classification algorithms may be suit
for different data resources. Hence, utilizing multiple
learning algorithms can obtain better predictive
performance.

Output

Reference

Candidate genes
List of genes
Ranking and test statistics
Region, list of genes and genome Ranking and test statistics
Region and list of genes
Ranking and selection of candidates

[91]
[92]
[93]

Genome

Ranking and test statistics

[94]

Region, list of genes and genome
Region
List of genes
List of genes
List of genes

Ranking and test statistics
Ranking
Ranking
Ranking
Ranking

[95]
[96]
[97]
[98]
[83]
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web tools on the basis of their data. In training data,
three kinds of data, known disease genes, keywords
(disease name), and gene expression, are viewed as
priori knowledge. The ToppNet [91] only need provide
a set of known genes while others need specify
keywords. The outputs of all web tools contain the rank
of candidate disease gene. Some tools like ToppNet[91] ,
PINTA[92] , and ENDEAVOUR[95] are giving score. The
outputs of genomic-based tools contain candidate
genes. In addition, some-tools are able to integrate other
data resources except PPI data. The PINTA[92] provides
comparative analysis with gene expression data and
Endeavour[95] can integrate GO, literature, sequence,
gene expression, and motif into result.
4.2

Standalone programs

The standalone tools are easy to be overlooked as
most of user lack of professional skills. However,
it shows advantage in large-scale disease gene
prioritization. ProphNet[98] (free MATLAB code can be
downloaded from http://genome2.ugr.es/prophnet) is
a network-based gene prioritization tool which allows
users integrate different biological entities. ProDiGe[83]
(free MATLAB code can be downloaded from
http://cbio.ensmp.fr/jFvert/svn/prodige/html/) is a
gene prioritization tool mentioned above.

5

Conclusions and Future Research

The goal of gene prioritization is to identify the
most likely disease genes among a large number
of candidates to a particular disease. It can assist
geneticists and molecular biologists to elucidate the
genetic basis of human diseases. Further, it also
contributes to the diagnosis, prevention, and treatment
of human diseases[99, 100] . With the development
of high-throughput technologies, PPI data has
increased sharply in the past decade. These giant
data is viewed as an important resource for protein
complex identification[101, 102] , essential protein
discovery[103, 104] , and disease gene research[34] . Many
computational approaches have been proposed to
prioritize candidate disease genes based on PPI data. In
this paper, we have reviewed the recently advanced
computational approaches for candidate disease gene
prioritization. Although prioritization methods have
achieved a great success in the past few years[105] , there
are some further researches that are needed to improve
these methods.
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(1) It cannot be ignored that current available
PPI data contain large amounts of false positive
and false negative noises. It has been shown that
integrating other types of biological data into PPI
data can improve performance of disease gene
prioritization[106–108] . However, it is still challenging
to combine multiple data resources with PPI data
appropriately for disease gene prioritization. For
example, some approaches score different data
resources separately and obtain the final rank of genes
by summing these scores. Therefore, methods for
effectively integrating various data resources into a PPI
network are needed to develop to improve network
quality for gene prioritization.
(2) It has been proved that disease progression is
dynamic, involving differentially expressed genes and
proteins during different periods[109] . Comparing to
static PPI network, dynamic PPI network can illustrate
how the onset and progression of disease are reflected in
the form of differentially expressed genes[110] . It could
be a new direction for candidate gene prioritization
based on dynamic PPI network in the future.
(3) Different methods make use of different
biological data to prioritize disease genes. The
criteria of data selection and data integration may be
different. These differences give rise to biases among
different approaches. Therefore, it is still challenging to
design suitable strategy for assessing the performance
of different gene prioritization methods.
(4) Some computational tools based on PPI network
have been developed to prioritize candidate disease
genes. Although these tools have achieved great
successes, some improvements are still necessary. For
example, some tools only provide the ranking of
candidate disease genes in the final report. It would
be better to provide more supplemental information
such as P values of ranking and topological features
of candidate disease genes to enhance confidence of
results. The web tools are easy to get result with few
simple step. Therefore, if the user has few disease data
and without excellent computer skills, it is suggested
to use web tools. While the researcher would like
to prioritize large-scale disease gene, it should use
standalone tools instead. In addition, as different tools
have different strengths and weaknesses, it is advisable
for user to obtain the result with multiple tools instead
of a single one.
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